missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Caveolin 2 Polyclonal Antibody

Goat Polyclonal Antibody
Brand: Invitrogen™ PA5149071
This item is not returnable.
View return policy
Description
Reconstitute at 0.2 mg/mL in sterile PBS.
Caveolae are specialized domains of the plasma membrane that are implicated in the sequestration of a variety of lipid and protein molecules. It has been suggested that these important cellular organelles have a pivotal role in such diverse biochemical processes as lipid metabolism, growth regulation, signal transduction, and apoptosis. Caveolin interacts with and regulates heterotrimeric G-proteins. Currently, there are three members of the caveolin multigene family which are known to encode 21-24 kDa integral membrane proteins that comprise the major structural component of the caveolar membrane in vivo. Caveolin-2 protein is abundantly expressed in fibroblasts and differentiated adipocytes, smooth and skeletal muscle, and endothelial cells. The expression of caveolin-1 is similar to that of caveolin-2 while caveolin-3 expression appears to be limited to muscle tissue types.
Specifications
| Caveolin 2 | |
| Polyclonal | |
| Unconjugated | |
| CAV2 | |
| AI447843; CAV; CAV2; caveolae; caveolae protein, 20-kD; caveolin 2; caveolin 2 isoform a and b; caveolin-2; MGC12294; Phospho-CAV2 | |
| Goat | |
| Antigen affinity chromatography | |
| RUO | |
| 12390, 363425, 858 | |
| Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
| Lyophilized |
| Immunohistochemistry (Paraffin), Western Blot, Immunocytochemistry | |
| 0.2 mg/mL | |
| PBS with trehalose and no preservative | |
| P51636, Q2IBC5, Q9WVC3 | |
| CAV2 | |
| E. coli-derived recombinant human Caveolin-2, Met1-Lys86. | |
| 100 μg | |
| Primary | |
| Human, Mouse, Rat | |
| Antibody | |
| IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction